GENOKEY ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.7% 3.7% 1.8% 4.4% 2.6%  
Credit score (0-100)  53 53 71 46 61  
Credit rating  BBB BBB A BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 1.5 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Gross profit  -55.9 -220 4,021 -102 -18.0  
EBITDA  -55.9 -232 4,021 -102 -18.0  
EBIT  -55.9 -232 4,021 -102 -18.0  
Pre-tax profit (PTP)  -603.1 -529.5 3,992.6 -851.7 -609.7  
Net earnings  -472.8 -410.7 2,900.5 -450.7 -494.7  
Pre-tax profit without non-rec. items  -603 -529 3,993 -852 -610  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -1,796 -2,206 694 244 -251  
Interest-bearing liabilities  2,006 1,427 0.0 0.0 0.0  
Balance sheet total (assets)  8,648 8,594 12,594 12,974 7,517  

Net Debt  2,006 1,400 -7.7 -3.3 -1.3  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -55.9 -220 4,021 -102 -18.0  
Gross profit growth  53.1% -294.3% 0.0% 0.0% 82.3%  
Employees  1 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  8,648 8,594 12,594 12,974 7,517  
Balance sheet change%  -1.8% -0.6% 46.5% 3.0% -42.1%  
Added value  -55.9 -231.6 4,021.0 -101.9 -18.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  42 0 -8,543 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 1.0 -1.0 -2.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 105.1% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.5% -2.2% 34.4% -0.8% -0.2%  
ROI %  -0.5% -2.2% 36.7% -0.9% -0.2%  
ROE %  -5.4% -4.8% 62.5% -96.1% -12.7%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  -17.2% -20.4% 5.5% 1.9% -3.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -3,589.4% -604.8% -0.2% 3.3% 7.1%  
Gearing %  -111.7% -64.7% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  27.3% 17.4% 4.0% 0.0% 0.0%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  0.2 0.2 0.6 0.2 48.9  
Current Ratio  0.2 0.2 0.6 0.2 48.9  
Cash and cash equivalent  0.0 26.8 7.7 3.3 1.3  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -442.0 -187.3 -4.3 -11.6 735.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -56 -232 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -56 -232 0 0 0  
EBIT / employee  -56 -232 0 0 0  
Net earnings / employee  -473 -411 0 0 0